Loading...
Loading...
African Journal of Biology and Medical Research
Vol. 8Issue 22025pp. 13–24Published 30 April 2025
DOI 10.52589/AJBMR-CFMVGORVResearch Article
Share Link
Cite this
Citation unavailable for this article.
Abstract:
Epilepsy is a neurological disorder characterized by recurrent seizures, and current anti-epileptic drugs often have side effects. Curcuma longa, commonly known as turmeric, has been traditionally used for various medicinal purposes, including the treatment of neurological disorders. This study investigates the neuroprotective effects of Curcuma longa in pentylenetetrazol (PTZ)-induced epilepsy in albino rats. Group one received normal feed (control), Group two received PTZ to induce epilepsy intraperitoneally. Group three received PTZ with feed, Group four received a low dose of Curcuma longa with PTZ, and Group five received high dose of Curcuma longa with PTZ. The experiment lasted for 28 days, during which seizure severity and neurotoxicity were assessed. The results revealed that PTZ administration significantly increased seizure severity and frequency, as well as oxidative stress and neuroinflammatory markers. Treatment with Curcuma longa extract, particularly at the low dose and high dose, significantly reduced oxidative stress and neuro inflammation and improving neuroprotection. These findings suggest that Curcuma longa extract may have potential neuroprotective effects and anticonvulsant property making it a promising candidate for adjunctive therapy in epilepsy management.
Disclaimer/Publisher’s Note
The statements, opinions and data contained in this publication are solely those of the author(s) and contributor(s) and not of AB Journals or its editors. AB Journals remains neutral and accepts no responsibility for any injury or damage resulting from ideas, methods, instructions or products referred to in the content.
Copyrights